微信公众号

官网二维码

中国癌症防治杂志 ›› 2015, Vol. 7 ›› Issue (5): 325-329.doi: DOI:10.3969/j.issn.1674-5671.2015.05.03

• 基础研究 • 上一篇    下一篇

p38 MAPK/p53信号通路调控骨肉瘤细胞中Ether à go-go表达的研究

  

  1. 厦门大学附属东南医院  1骨科,2神经内科
  • 出版日期:2015-10-25 发布日期:2015-11-11
  • 通讯作者: 林斌 E-mail:linbin813@163.com
  • 基金资助:

    国家自然科学基金资助项目(81402217)

The p38 MAPK/p53 pathway regulates expression of Ether à go-go in osteosarcoma

  • Online:2015-10-25 Published:2015-11-11

摘要:

目的 检测Ether à go-go (Eag) 在人骨肉瘤细胞中的表达并探索其调控的分子机制。方法 采用实时定量逆转录-聚合酶链反应 (reverse transcription polymerase chain reaction, RT-PCR) 和免疫印迹技术 (Western blot,WB) 检测骨肉瘤细胞MG-63中Eag的表达。体外实验检测Eag抑制剂对MG-63细胞增殖的影响,体内实验检测Eag短发卡RNA (short hairpin RNA, shRNA) 对裸鼠骨肉瘤生长的影响。最后用WB检测骨肉瘤细胞中促有丝分裂原活化蛋白激酶(mitogen-activated protein kinase, MAPK) 和p53蛋白的表达水平。 结果 Eag在MG-63细胞中高表达,Eag shRNA或抑制剂丙咪嗪(Imipramine) 能从体内外有效地抑制人骨肉瘤细胞增殖。p38 MAPK抑制剂SB203580或小干扰RNA (small interference RNA, siRNA) 可抑制MG-63细胞的增殖,同时诱导p53的表达。p53激活剂nutlin-3可抑制MG-63细胞增殖并下调Eag的表达,而p53抑制剂pifithrin-alpha (PFT-α) 则能促进MG-63细胞增殖并诱导Eag的表达。 结论 Eag作为癌基因参与了骨肉瘤细胞增殖过程,其可能受p38 MAPK/p53信号通路的调控。

关键词: 骨肿瘤, Ether à, go-go通道, 细胞增殖, MAPK信号通路, p53基因, 调控, 表达

Abstract:

Objective To detect the expression of Ether à go-go(Eag) in human osteosarcoma and examine possible pathways regulating Eag expression. Methods Eag expression was analyzed in the osteosarcoma cell line MG-63 using reverse transcription-polymerase chain reaction and western blotting. Effects of Eag inhibition on cell proliferation were examined in MG-63 cultures, and effects of short hairpin RNA-mediated knockdown of Eag on osteosarcoma growth were examined in an in vivo xenograft model. Activation of the mitogen-activated protein kinase(MAPK)/p53 signaling pathway in MG-63 cells was detected using Western blot analysis. Results Eag is overexpressed in MG-63 cells, and imipramine or Eag short hairpin RNA significantly inhibited MG-63 proliferation in vitro and in vivo. MG-63 proliferation was also strongly inhibited by the p38 MAPK inhibitor SB203580 or small interfering RNA (siRNA). Using SB203580 or siRNA to inhibit p38 MAPK activation reduced levels of Eag protein but increased levels of p53 protein. Using nutlin-3 to activate p53 reduced levels of Eag protein and arrested MG-63 growth, while using pifithrin-alpha to inactivate p53 increased the levels of Eag and promoted MG-63 growth. Conclusion The Eag gene functions as an oncogene to promote the proliferation of osteosarcoma cells,and the p38 MAPK/p53 pathway regulates high Eag expression in osteosarcoma cells.

Key words: Bone neoplasm, Ether à, go-go, Cell proliferation, MAPK pathway, p53 gene, Regulation, Expression